In today’s briefing:
- 111’s Opportunistic US$3.66 Bid from the Co-Founders
- ECM Weekly (12th Sep 2022) – Onewo, CALB, YSB, Medanta, Beneunder, JMDC, SH Holdings, Indigo
- China Internet Weekly (12Aug2022): Tencent, JD.com, Meituan, NetEase, Inkeverse
- Pre-IPO Innovex Medical – A Comprehensive Product Portfolio Underpins Future Growth Prospects
- Morning Views Asia: China SCE, Yuexiu Property
- Morning Views Asia: China SCE, Yuexiu Property
111’s Opportunistic US$3.66 Bid from the Co-Founders
- 111 Inc (YI US), the largest virtual pharmacy network in China, disclosed a privatisation proposal from a co-founder-led consortium at US$3.66 per ADS, a 20.0% premium to the undisturbed price.
- For privatisation to succeed, shareholders representing two-thirds of shares present and voting need to approve the deal. The co-founders represent 92.04% of the total voting power.
- The offer price is unattractive but this is a done deal. At the last close, the gross and annualised spread for a January 2023 completion is 11.6% and 33.4%, respectively.
ECM Weekly (12th Sep 2022) – Onewo, CALB, YSB, Medanta, Beneunder, JMDC, SH Holdings, Indigo
- Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
- On the IPO front, a few large Hong Kong IPOs are lining up to launch soon.
- Placements picked up this week in Japan and India with most being secondary deals.
China Internet Weekly (12Aug2022): Tencent, JD.com, Meituan, NetEase, Inkeverse
- Tencent invested more in Ubisoft Entertainment, a French game developer.
- The monthly active users of local life recovered in China in June and July.
- NetEase will close Music Street, the social networking-oriented karaoke app.
Pre-IPO Innovex Medical – A Comprehensive Product Portfolio Underpins Future Growth Prospects
- As one of the few companies in the world that could provide one-stop solutions including all major medical devices used in non-vascular interventional surgery, Innovex’s outlook is promising.
- About 30% overseas revenue indicates that the Company’s internationalization is on track, which could help to “hedge” negative domestic policy risks.
- In terms of the valuation, Innovex’s valuation should be higher than Scivita but lower than Aohua. However, Innovex has the potential to surpass Aohua in the future.
Morning Views Asia: China SCE, Yuexiu Property
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.
Morning Views Asia: China SCE, Yuexiu Property
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars